NASDAQ | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is designed to provide exposure toU. S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 7.61% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 7.59% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 7.38% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 7.09% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 6.56% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 3.84% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.77% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.71% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.54% |
| CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 3.54% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.53% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.43% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.42% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.40% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.03% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 2.20% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.18% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 1.92% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.53% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.52% |